APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nut Allergy Therapeutics

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Nut Allergy Therapeutics Market Analysis and Forecast 2026-2032

2 January 2026194 pages

Choose your research edition.

Industry ResearchNut Allergy Therapeutics Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Nut Allergy Therapeutics Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Nut Allergy Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nut Allergy Therapeutics Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Nut Allergy Therapeutics Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Nut Allergy Therapeutics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Nut Allergy Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Nut Allergy Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Nut Allergy Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Nut Allergy Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Nut Allergy Therapeutics include J & J, HUAPONT Pharm, GSK, Bayer, Viatris, UCB Pharma, Perrigo, Kaleo and Amneal Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Nut Allergy Therapeutics, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Nut Allergy Therapeutics, also provides the revenue of main regions and countries. Of the upcoming market potential for Nut Allergy Therapeutics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nut Allergy Therapeutics revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nut Allergy Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Nut Allergy Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Nut Allergy Therapeutics Segment by Company

J & J

HUAPONT Pharm

GSK

Bayer

Viatris

UCB Pharma

Perrigo

Kaleo

Amneal Pharma

ALK Abello

Aimmune Therapeutics

Nut Allergy Therapeutics Segment by Type

Epinephrine Injection

Antihistamines

Other

Nut Allergy Therapeutics Segment by Application

Hospital Pharmacy

Retail Pharmacy

Other

Nut Allergy Therapeutics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nut Allergy Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nut Allergy Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nut Allergy Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Nut Allergy Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Nut Allergy Therapeutics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nut Allergy Therapeutics revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nut Allergy Therapeutics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Epinephrine Injection Major Player Table 3. Antihistamines Major Player Table 4. Other Major Player Table 5. Global Nut Allergy Therapeutics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Pharmacy Major Player Table 7. Retail Pharmacy Major Player Table 8. Other Major Player Table 9. Nut Allergy Therapeutics Industry Trends Table 10. Nut Allergy Therapeutics Industry Drivers Table 11. Nut Allergy Therapeutics Industry Opportunities and Challenges Table 12. Nut Allergy Therapeutics Industry Restraints Table 13. Global Nut Allergy Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Nut Allergy Therapeutics Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Nut Allergy Therapeutics Market Share by Region (2021-2026) Table 16. Global Nut Allergy Therapeutics Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Nut Allergy Therapeutics Market Share by Region (2027-2032) Table 18. Global Nut Allergy Therapeutics Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Nut Allergy Therapeutics Revenue Market Share by Players (2021-2026) Table 20. Global Nut Allergy Therapeutics Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Nut Allergy Therapeutics Key Players Headquarters & Area Served Table 22. Global Nut Allergy Therapeutics Players, Product Type & Application Table 23. Global Nut Allergy Therapeutics Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Nut Allergy Therapeutics by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Nut Allergy Therapeutics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Nut Allergy Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Nut Allergy Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Nut Allergy Therapeutics Revenue Market Share by Type (2021-2026) Table 30. Global Nut Allergy Therapeutics Revenue Market Share by Type (2027-2032) Table 31. Global Nut Allergy Therapeutics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Nut Allergy Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Nut Allergy Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Nut Allergy Therapeutics Revenue Market Share by Application (2021-2026) Table 35. Global Nut Allergy Therapeutics Revenue Market Share by Application (2027-2032) Table 36. J & J Company Information Table 37. J & J Business Overview Table 38. J & J Nut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. J & J Nut Allergy Therapeutics Product Portfolio Table 40. J & J Recent Development Table 41. HUAPONT Pharm Company Information Table 42. HUAPONT Pharm Business Overview Table 43. HUAPONT Pharm Nut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. HUAPONT Pharm Nut Allergy Therapeutics Product Portfolio Table 45. HUAPONT Pharm Recent Development Table 46. GSK Company Information Table 47. GSK Business Overview Table 48. GSK Nut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. GSK Nut Allergy Therapeutics Product Portfolio Table 50. GSK Recent Development Table 51. Bayer Company Information Table 52. Bayer Business Overview Table 53. Bayer Nut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Bayer Nut Allergy Therapeutics Product Portfolio Table 55. Bayer Recent Development Table 56. Viatris Company Information Table 57. Viatris Business Overview Table 58. Viatris Nut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Viatris Nut Allergy Therapeutics Product Portfolio Table 60. Viatris Recent Development Table 61. UCB Pharma Company Information Table 62. UCB Pharma Business Overview Table 63. UCB Pharma Nut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. UCB Pharma Nut Allergy Therapeutics Product Portfolio Table 65. UCB Pharma Recent Development Table 66. Perrigo Company Information Table 67. Perrigo Business Overview Table 68. Perrigo Nut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Perrigo Nut Allergy Therapeutics Product Portfolio Table 70. Perrigo Recent Development Table 71. Kaleo Company Information Table 72. Kaleo Business Overview Table 73. Kaleo Nut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Kaleo Nut Allergy Therapeutics Product Portfolio Table 75. Kaleo Recent Development Table 76. Amneal Pharma Company Information Table 77. Amneal Pharma Business Overview Table 78. Amneal Pharma Nut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Amneal Pharma Nut Allergy Therapeutics Product Portfolio Table 80. Amneal Pharma Recent Development Table 81. ALK Abello Company Information Table 82. ALK Abello Business Overview Table 83. ALK Abello Nut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. ALK Abello Nut Allergy Therapeutics Product Portfolio Table 85. ALK Abello Recent Development Table 86. Aimmune Therapeutics Company Information Table 87. Aimmune Therapeutics Business Overview Table 88. Aimmune Therapeutics Nut Allergy Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Aimmune Therapeutics Nut Allergy Therapeutics Product Portfolio Table 90. Aimmune Therapeutics Recent Development Table 91. North America Nut Allergy Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 92. North America Nut Allergy Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 93. North America Nut Allergy Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 94. North America Nut Allergy Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 95. North America Nut Allergy Therapeutics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. North America Nut Allergy Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 97. North America Nut Allergy Therapeutics Revenue by Country (US$ Million) & (2027-2032) Table 98. Europe Nut Allergy Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 99. Europe Nut Allergy Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 100. Europe Nut Allergy Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 101. Europe Nut Allergy Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 102. Europe Nut Allergy Therapeutics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Europe Nut Allergy Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 104. Europe Nut Allergy Therapeutics Revenue by Country (US$ Million) & (2027-2032) Table 105. China Nut Allergy Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 106. China Nut Allergy Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 107. China Nut Allergy Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 108. China Nut Allergy Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 109. Asia Nut Allergy Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 110. Asia Nut Allergy Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 111. Asia Nut Allergy Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 112. Asia Nut Allergy Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 113. Asia Nut Allergy Therapeutics Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Asia Nut Allergy Therapeutics Revenue by Region (US$ Million) & (2021-2026) Table 115. Asia Nut Allergy Therapeutics Revenue by Region (US$ Million) & (2027-2032) Table 116. SAMEA Nut Allergy Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 117. SAMEA Nut Allergy Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 118. SAMEA Nut Allergy Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 119. SAMEA Nut Allergy Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 120. SAMEA Nut Allergy Therapeutics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. SAMEA Nut Allergy Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 122. SAMEA Nut Allergy Therapeutics Revenue by Country (US$ Million) & (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Nut Allergy Therapeutics Image Figure 2. Global Nut Allergy Therapeutics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nut Allergy Therapeutics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Epinephrine Injection Image Figure 5. Antihistamines Image Figure 6. Other Image Figure 7. Global Nut Allergy Therapeutics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Nut Allergy Therapeutics Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Pharmacy Image Figure 10. Retail Pharmacy Image Figure 11. Other Image Figure 12. Global Nut Allergy Therapeutics Market Size (US$ Million) & (2021-2032) Figure 13. Global Nut Allergy Therapeutics Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Nut Allergy Therapeutics Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Nut Allergy Therapeutics Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Nut Allergy Therapeutics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Nut Allergy Therapeutics Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Nut Allergy Therapeutics Revenue Market Share by Type (2021-2032) Figure 20. Global Nut Allergy Therapeutics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Nut Allergy Therapeutics Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Nut Allergy Therapeutics Revenue Market Share by Application (2021-2032) Figure 23. North America Nut Allergy Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Nut Allergy Therapeutics Revenue Share by Type (2021-2032) Figure 25. North America Nut Allergy Therapeutics Revenue Share by Application (2021-2032) Figure 26. North America Nut Allergy Therapeutics Revenue Share by Country (2021-2032) Figure 27. United States Nut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Nut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Nut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Nut Allergy Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Nut Allergy Therapeutics Revenue Share by Type (2021-2032) Figure 32. Europe Nut Allergy Therapeutics Revenue Share by Application (2021-2032) Figure 33. Europe Nut Allergy Therapeutics Revenue Share by Country (2021-2032) Figure 34. Germany Nut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Nut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Nut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Nut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Nut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Nut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Nut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Nut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Nut Allergy Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Nut Allergy Therapeutics Revenue Share by Type (2021-2032) Figure 44. China Nut Allergy Therapeutics Revenue Share by Application (2021-2032) Figure 45. Asia Nut Allergy Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Nut Allergy Therapeutics Revenue Share by Type (2021-2032) Figure 47. Asia Nut Allergy Therapeutics Revenue Share by Application (2021-2032) Figure 48. Asia Nut Allergy Therapeutics Revenue Share by Region (2021-2032) Figure 49. Japan Nut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Nut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Nut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Nut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Nut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Nut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Nut Allergy Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Nut Allergy Therapeutics Revenue Share by Type (2021-2032) Figure 57. SAMEA Nut Allergy Therapeutics Revenue Share by Application (2021-2032) Figure 58. SAMEA Nut Allergy Therapeutics Revenue Share by Country (2021-2032) Figure 59. Brazil Nut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Nut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Nut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Nut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Nut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Nut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Nut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Nut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Nut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Nut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Nut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Epinephrine Injection
  • Antihistamines
  • Other
Applications
  • Hospital Pharmacy
  • Retail Pharmacy
  • Other
Companies covered
  • J & J
  • HUAPONT Pharm
  • GSK
  • Bayer
  • Viatris
  • UCB Pharma
  • Perrigo
  • Kaleo
  • Amneal Pharma
  • ALK Abello
  • Aimmune Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Nut Allergy Therapeutics Market by Type
  3. 1.2.1 Global Nut Allergy Therapeutics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Epinephrine Injection
  5. 1.2.3 Antihistamines
  6. 1.2.4 Other
  7. 1.3 Nut Allergy Therapeutics Market by Application
  8. 1.3.1 Global Nut Allergy Therapeutics Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital Pharmacy
  10. 1.3.3 Retail Pharmacy
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Nut Allergy Therapeutics Market Dynamics
  1. 2.1 Nut Allergy Therapeutics Industry Trends
  2. 2.2 Nut Allergy Therapeutics Industry Drivers
  3. 2.3 Nut Allergy Therapeutics Industry Opportunities and Challenges
  4. 2.4 Nut Allergy Therapeutics Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Nut Allergy Therapeutics Market Perspective (2021-2032)
  2. 3.2 Global Nut Allergy Therapeutics Growth Trends by Region
  3. 3.2.1 Global Nut Allergy Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Nut Allergy Therapeutics Market Size by Region (2021-2026)
  5. 3.2.3 Global Nut Allergy Therapeutics Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Nut Allergy Therapeutics Revenue by Players
  2. 4.1.1 Global Nut Allergy Therapeutics Revenue by Players (2021-2026)
  3. 4.1.2 Global Nut Allergy Therapeutics Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Nut Allergy Therapeutics Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Nut Allergy Therapeutics Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Nut Allergy Therapeutics Key Players Headquarters & Area Served
  7. 4.4 Global Nut Allergy Therapeutics Players, Product Type & Application
  8. 4.5 Global Nut Allergy Therapeutics Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Nut Allergy Therapeutics Market CR5 and HHI
  11. 4.6.3 2025 Nut Allergy Therapeutics Tier 1, Tier 2, and Tier 3
5 Nut Allergy Therapeutics Market Size by Type
  1. 5.1 Global Nut Allergy Therapeutics Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Nut Allergy Therapeutics Revenue by Type (2021-2032)
  3. 5.3 Global Nut Allergy Therapeutics Revenue Market Share by Type (2021-2032)
6 Nut Allergy Therapeutics Market Size by Application
  1. 6.1 Global Nut Allergy Therapeutics Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Nut Allergy Therapeutics Revenue by Application (2021-2032)
  3. 6.3 Global Nut Allergy Therapeutics Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 J & J
  2. 7.1.1 J & J Company Information
  3. 7.1.2 J & J Business Overview
  4. 7.1.3 J & J Nut Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  5. 7.1.4 J & J Nut Allergy Therapeutics Product Portfolio
  6. 7.1.5 J & J Recent Developments
  7. 7.2 HUAPONT Pharm
  8. 7.2.1 HUAPONT Pharm Company Information
  9. 7.2.2 HUAPONT Pharm Business Overview
  10. 7.2.3 HUAPONT Pharm Nut Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  11. 7.2.4 HUAPONT Pharm Nut Allergy Therapeutics Product Portfolio
  12. 7.2.5 HUAPONT Pharm Recent Developments
  13. 7.3 GSK
  14. 7.3.1 GSK Company Information
  15. 7.3.2 GSK Business Overview
  16. 7.3.3 GSK Nut Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  17. 7.3.4 GSK Nut Allergy Therapeutics Product Portfolio
  18. 7.3.5 GSK Recent Developments
  19. 7.4 Bayer
  20. 7.4.1 Bayer Company Information
  21. 7.4.2 Bayer Business Overview
  22. 7.4.3 Bayer Nut Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Bayer Nut Allergy Therapeutics Product Portfolio
  24. 7.4.5 Bayer Recent Developments
  25. 7.5 Viatris
  26. 7.5.1 Viatris Company Information
  27. 7.5.2 Viatris Business Overview
  28. 7.5.3 Viatris Nut Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Viatris Nut Allergy Therapeutics Product Portfolio
  30. 7.5.5 Viatris Recent Developments
  31. 7.6 UCB Pharma
  32. 7.6.1 UCB Pharma Company Information
  33. 7.6.2 UCB Pharma Business Overview
  34. 7.6.3 UCB Pharma Nut Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  35. 7.6.4 UCB Pharma Nut Allergy Therapeutics Product Portfolio
  36. 7.6.5 UCB Pharma Recent Developments
  37. 7.7 Perrigo
  38. 7.7.1 Perrigo Company Information
  39. 7.7.2 Perrigo Business Overview
  40. 7.7.3 Perrigo Nut Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Perrigo Nut Allergy Therapeutics Product Portfolio
  42. 7.7.5 Perrigo Recent Developments
  43. 7.8 Kaleo
  44. 7.8.1 Kaleo Company Information
  45. 7.8.2 Kaleo Business Overview
  46. 7.8.3 Kaleo Nut Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Kaleo Nut Allergy Therapeutics Product Portfolio
  48. 7.8.5 Kaleo Recent Developments
  49. 7.9 Amneal Pharma
  50. 7.9.1 Amneal Pharma Company Information
  51. 7.9.2 Amneal Pharma Business Overview
  52. 7.9.3 Amneal Pharma Nut Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Amneal Pharma Nut Allergy Therapeutics Product Portfolio
  54. 7.9.5 Amneal Pharma Recent Developments
  55. 7.10 ALK Abello
  56. 7.10.1 ALK Abello Company Information
  57. 7.10.2 ALK Abello Business Overview
  58. 7.10.3 ALK Abello Nut Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  59. 7.10.4 ALK Abello Nut Allergy Therapeutics Product Portfolio
  60. 7.10.5 ALK Abello Recent Developments
  61. 7.11 Aimmune Therapeutics
  62. 7.11.1 Aimmune Therapeutics Company Information
  63. 7.11.2 Aimmune Therapeutics Business Overview
  64. 7.11.3 Aimmune Therapeutics Nut Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Aimmune Therapeutics Nut Allergy Therapeutics Product Portfolio
  66. 7.11.5 Aimmune Therapeutics Recent Developments
8 North America
  1. 8.1 North America Nut Allergy Therapeutics Revenue (2021-2032)
  2. 8.2 North America Nut Allergy Therapeutics Revenue by Type (2021-2032)
  3. 8.2.1 North America Nut Allergy Therapeutics Revenue by Type (2021-2026)
  4. 8.2.2 North America Nut Allergy Therapeutics Revenue by Type (2027-2032)
  5. 8.3 North America Nut Allergy Therapeutics Revenue Share by Type (2021-2032)
  6. 8.4 North America Nut Allergy Therapeutics Revenue by Application (2021-2032)
  7. 8.4.1 North America Nut Allergy Therapeutics Revenue by Application (2021-2026)
  8. 8.4.2 North America Nut Allergy Therapeutics Revenue by Application (2027-2032)
  9. 8.5 North America Nut Allergy Therapeutics Revenue Share by Application (2021-2032)
  10. 8.6 North America Nut Allergy Therapeutics Revenue by Country
  11. 8.6.1 North America Nut Allergy Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Nut Allergy Therapeutics Revenue by Country (2021-2026)
  13. 8.6.3 North America Nut Allergy Therapeutics Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Nut Allergy Therapeutics Revenue (2021-2032)
  2. 9.2 Europe Nut Allergy Therapeutics Revenue by Type (2021-2032)
  3. 9.2.1 Europe Nut Allergy Therapeutics Revenue by Type (2021-2026)
  4. 9.2.2 Europe Nut Allergy Therapeutics Revenue by Type (2027-2032)
  5. 9.3 Europe Nut Allergy Therapeutics Revenue Share by Type (2021-2032)
  6. 9.4 Europe Nut Allergy Therapeutics Revenue by Application (2021-2032)
  7. 9.4.1 Europe Nut Allergy Therapeutics Revenue by Application (2021-2026)
  8. 9.4.2 Europe Nut Allergy Therapeutics Revenue by Application (2027-2032)
  9. 9.5 Europe Nut Allergy Therapeutics Revenue Share by Application (2021-2032)
  10. 9.6 Europe Nut Allergy Therapeutics Revenue by Country
  11. 9.6.1 Europe Nut Allergy Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Nut Allergy Therapeutics Revenue by Country (2021-2026)
  13. 9.6.3 Europe Nut Allergy Therapeutics Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Nut Allergy Therapeutics Revenue (2021-2032)
  2. 10.2 China Nut Allergy Therapeutics Revenue by Type (2021-2032)
  3. 10.2.1 China Nut Allergy Therapeutics Revenue by Type (2021-2026)
  4. 10.2.2 China Nut Allergy Therapeutics Revenue by Type (2027-2032)
  5. 10.3 China Nut Allergy Therapeutics Revenue Share by Type (2021-2032)
  6. 10.4 China Nut Allergy Therapeutics Revenue by Application (2021-2032)
  7. 10.4.1 China Nut Allergy Therapeutics Revenue by Application (2021-2026)
  8. 10.4.2 China Nut Allergy Therapeutics Revenue by Application (2027-2032)
  9. 10.5 China Nut Allergy Therapeutics Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Nut Allergy Therapeutics Revenue (2021-2032)
  2. 11.2 Asia Nut Allergy Therapeutics Revenue by Type (2021-2032)
  3. 11.2.1 Asia Nut Allergy Therapeutics Revenue by Type (2021-2026)
  4. 11.2.2 Asia Nut Allergy Therapeutics Revenue by Type (2027-2032)
  5. 11.3 Asia Nut Allergy Therapeutics Revenue Share by Type (2021-2032)
  6. 11.4 Asia Nut Allergy Therapeutics Revenue by Application (2021-2032)
  7. 11.4.1 Asia Nut Allergy Therapeutics Revenue by Application (2021-2026)
  8. 11.4.2 Asia Nut Allergy Therapeutics Revenue by Application (2027-2032)
  9. 11.5 Asia Nut Allergy Therapeutics Revenue Share by Application (2021-2032)
  10. 11.6 Asia Nut Allergy Therapeutics Revenue by Country
  11. 11.6.1 Asia Nut Allergy Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Nut Allergy Therapeutics Revenue by Country (2021-2026)
  13. 11.6.3 Asia Nut Allergy Therapeutics Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Nut Allergy Therapeutics Revenue (2021-2032)
  2. 12.2 SAMEA Nut Allergy Therapeutics Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Nut Allergy Therapeutics Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Nut Allergy Therapeutics Revenue by Type (2027-2032)
  5. 12.3 SAMEA Nut Allergy Therapeutics Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Nut Allergy Therapeutics Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Nut Allergy Therapeutics Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Nut Allergy Therapeutics Revenue by Application (2027-2032)
  9. 12.5 SAMEA Nut Allergy Therapeutics Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Nut Allergy Therapeutics Revenue by Country
  11. 12.6.1 SAMEA Nut Allergy Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Nut Allergy Therapeutics Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Nut Allergy Therapeutics Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst